The updated, revised Second Edition of this book is more than twice the size, twice as enjoyable, and, given today's pharmacopolitical climate, twice as relevant as its predecessor. Enhanced by many more real-world examples, more up-to-date tables and charts, and revamped drawings and schematics, Multinational Pharmaceutical Companies features new, 90s-oriented chapters on costs and pricing, animal research,
pharmacopolitics, prescription to over-the-counter conversions, mergers and
joint ventures, licensing, patents, biotechnology, and legal issues. An entirely new section on the medical-marketing interface covers corporate issues, organizational and
staffing issues, and joint medical and…
